Covered recipient · General Payments record
JAMAL M BULLOCKS
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$10,040.58
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $556.48 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $200.30 | 2 |
| DAVOL INC. | $146.71 | 1 |
| Galderma Laboratories, L.P. | $84.32 | 1 |
| Medtronic, Inc. | $61.39 | 1 |
| ABBVIE INC. | $29.45 | 1 |
| Integra LifeSciences Corporation | $20.81 | 1 |
| TELA Bio, Inc. | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103389737 | CMS |
| Davol Inc. | $146.71 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127651344 | CMS |
| Galderma Laboratories, L.P. | $84.32 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145288333 | CMS |
| Integra LifeSciences Corporation | $20.81 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140100778 | CMS |
| Medtronic, Inc. | $61.39 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117077857 | CMS |
| REVANCE THERAPEUTICS, INC. | $120.74 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913655 | CMS |
| REVANCE THERAPEUTICS, INC. | $79.56 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147913657 | CMS |
| TELA Bio, Inc. | $13.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154223620 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.